ARTICLE | Distillery Therapeutics
Therapeutics: Transglutaminase 2 (TGM2; TG2)
August 20, 2015 7:00 AM UTC
In vitro and mouse studies suggest enhancing TGM2 levels could help treat cancer and ophthalmic diseases by inhibiting angiogenesis. In a human umbilical vein endothelial cell line, an shRNA targeting...